Great Basin Reports 112 U.S. Customers, Reaffirms Guidance for 2015 Customer Acquisition

May 28, 2015, 08:00 ET from Great Basin Scientific, Inc.

SALT LAKE CITY, May 28, 2015 /PRNewswire/ -- Great Basin Scientific, Inc. (NASDAQ: GBSN; GBSNU), a molecular diagnostics company, today announced continued expansion of the customer base utilizing the Great Basin sample-to-result molecular diagnostic technology during April and May. The Company reported a total of 112 revenue-generating customers in the United States as of May 27, 2015, a 10.3% increase over the 101 customers reported as of the prior quarter ending March 31, 2015. Active and scheduled customer evaluations, representing the Company's sales pipeline, are 44 as of May 27.

About Great Basin Scientific Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at

Forward-Looking Statements This press release includes forward-looking statement regarding events, trends and business prospects, which may affect our future operating results and financial position. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) our limited operating history and history or losses; (ii) our ability to develop and commercialize new products and the timing of commercialization; (iii) our ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2014. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.

Media Contact: Tony Russo, Ph.D. or Todd Davenport, Ph.D. Russo Partners, LLC 212.845.4251

Investor Relations Contact: Bob Yedid ICR 646.277.1250


SOURCE Great Basin Scientific, Inc.